Recto-intercostal Block for Coronary Artery Bypass Grafting
Launched by HASEKI TRAINING AND RESEARCH HOSPITAL · May 13, 2024
Trial Information
Current as of February 18, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method to help manage pain after heart surgery called coronary artery bypass grafting (CABG). Specifically, researchers want to see how well a technique called the recto-intercostal fascial plane block works in reducing pain and the need for opioid medications after the surgery. Participants will be divided into two groups: one will receive this new pain relief method, while the other will not, so that the researchers can compare the results. They will also look at how this method affects breathing, heart function, and the overall time spent in the hospital after surgery.
To be eligible for this trial, participants should be between the ages of 65 and 74 and scheduled to have CABG surgery with sternotomy, which is a type of chest surgery. They should also have a certain level of health as determined by a specific medical classification. However, those with certain conditions, such as allergies to local anesthetics or a history of severe organ dysfunction, will not be eligible. If you decide to participate, you can expect to be part of an important study that aims to improve pain management and recovery for future heart surgery patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients who will undergo CABG surgery with sternotomy
- • patients who have an American Society of Anesthesiologists (ASA) Physical Status classification of III to IV
- Exclusion Criteria:
- • refusal to participate
- • a history of neurological deficits or neuropathy affecting the thoracal innervation
- • infection at the site of block application
- • allergy to local anesthetics
- • epilepsy or treatment with antipsychotics
- • abuse of alcohol or drugs
- • previous surgery distorting the anatomy of the sternum, thorax or upper abdominal area
- • severe organ dysfunction ( kidney, liver and other); patients who fail at weaning after 12 hours of surgery.
Trial Officials
Berna Caliskan
Principal Investigator
Haseki Training and Research Hospital Anesthesiology and Reanimation Department
About Haseki Training And Research Hospital
Haseki Training and Research Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Istanbul, Turkey, the hospital combines extensive clinical expertise with a commitment to excellence in research, providing a collaborative environment for healthcare professionals and researchers. With a focus on a wide range of medical disciplines, Haseki Hospital aims to contribute to the scientific community by facilitating rigorous clinical studies that adhere to the highest ethical standards, ultimately enhancing treatment options and outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Sultangazi, Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0